Skip to content

Stem cell- based therapy in Asherman syndrome

Effects of transplantation of bone marrow, adipose, and endometrial stem cells on endometrium structure and fertility in Ashermans syndrom and endometrial atrophy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190306042948N1
Enrollment
10
Registered
2019-04-15
Start date
2019-05-22
Completion date
Unknown
Last updated
2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Asherman Syndrome. Condition 2: Endometrial Atrophy. Female infertility of uterine origin Female infertility of uterine origin

Interventions

Intervention group: Single Stem cells transplanted cell (10000000 cells).

Sponsors

Hamedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Infertile patients referred to the Fatemieh infertility department of Hamadan University of Medical Sciences who suffer from Asherman syndrome or thin endometrium and did not respond to common treatments such as hormone therapy and surgery.

Exclusion criteria

Exclusion criteria: Patients with cardiovascular, renal disorders Patients with Syphilis, Hepatitis, AIDS Patients with husband infertility factor Endometrial thickness more than 7 mm

Design outcomes

Primary

MeasureTime frame
Endometrial thickness. Timepoint: Before transplantation and every month for one year after cell therapy. Method of measurement: Ultrasonography.;Menstruation. Timepoint: Monthly for one year after transplantation. Method of measurement: Number of menstruation days and used pads.;Fertility percent. Timepoint: For one year following transplantation. Method of measurement: Routine pregnancy tests.

Secondary

MeasureTime frame
FSH. Timepoint: Before and three months following cell transplantation. Method of measurement: Blood sampling.;LH. Timepoint: Before and three months following cell transplantation. Method of measurement: Blood sampling.;Endometrial adhesion. Timepoint: Before and three month after cell transplantation. Method of measurement: Ultrasonography.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSara Soleimani Asl

Hamedan University of Medical Sciences

sr_soleimani@yahoo.com+98 81 3838 0572

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026